86830 Federal Register / Vol. 89, No. 211 / Thursday, October 31, 2024 / Notices 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Maria Dolores Arjona 

Mayor, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 806D, Bethesda, MD 20892, (301) 827– 

8578, dolores.arjonamayor@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA Panel: 

Investigation of Co-Occurring Conditions 

Across the Lifespan to Understand Down 

Syndrome. 

Date: November 22, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health 

Rockledge II 6701 Rockledge Drive Bethesda, 

MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Katherine M Malinda, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4140, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

0912, malindakm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–23– 

199: ClinGen Genomic Curation Expert 

Panels (U24). 

Date: November 25, 2024. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge, Drive 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Altaf Ahmad Dar, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 827–2680, 

altaf.dar@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Neurotoxicology and Alcohol. 

Date: November 25, 2024. 

Time: 11:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Alexei Kondratyev, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5200, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1785, kondratyevad@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 25, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–25335 Filed 10–30–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke, Interagency Pain 

Research Coordinating Committee Call 

for Committee Membership 

Nominations 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) (Department) 

has created the Interagency Pain 

Research Coordinating Committee 

(IPRCC) and is seeking nominations for 

this committee. 

DATES: Nominations are due by 5:00 

p.m. ET on December 17, 2024. 

ADDRESSES: Nominations must be 

submitted through the webform on the 

IPRCC website: https://

www.surveymonkey.com/r/IPRCCnomination-form. 

FOR FURTHER INFORMATION CONTACT: 

Leah Pogorzala, leah.pogorzala@nih.gov 

or 301–496–4228. 

SUPPLEMENTARY INFORMATION: As 

specified in Public Law 111–148 

(‘‘Patient Protection and Affordable Care 

Act’’) the Committee will: 

(A) develop a summary of advances in 

pain care research supported or 

conducted by the Federal agencies 

relevant to the diagnosis, prevention, 

and treatment of pain and diseases and 

disorders associated with pain; 

(B) identify critical gaps in basic and 

clinical research on the symptoms and 

causes of pain; 

(C) make recommendations to ensure 

that the activities of the National 

Institutes of Health and other Federal 

agencies are free of unnecessary 

duplication of effort; 

(D) make recommendations on how 

best to disseminate information on pain 

care; and (e) make recommendations on 

how to expand partnerships between 

public entities and private entities to 

expand collaborative, cross-cutting 

research. 

Membership on the committee will 

include six (6) non-Federal members 

from among scientists, physicians, and 

other health professionals and six (6) 

non-Federal members of the general 

public who are representatives of 

leading research, advocacy, and service 

organizations for individuals with painrelated conditions. Members will serve 

overlapping three year terms. It is 

anticipated that the committee will meet 

at least once a year. 

The Department strives to ensure that 

the membership of HHS Federal 

advisory committees is fairly balanced 

in terms of points of view represented 

and the committee’s function. Every 

effort is made to ensure that the views 

of diverse ethnic and racial groups and 

people with disabilities are represented 

on HHS Federal advisory committees, 

and the Department therefore, 

encourages nominations of qualified 

candidates from these groups. The 

Department also encourages geographic 

diversity in the composition of the 

Committee. Appointment to this 

Committee shall be made without 

discrimination on the basis of age, race, 

ethnicity, gender, sexual orientation, 

disability, and cultural, religious, or 

socioeconomic status. 

The Department is soliciting 

nominations for non-federal members 

from among scientists, physicians, and 

other health professionals and for nonfederal members of the public who 

represent a leading research, advocacy, 

or service organization for people with 

pain-related conditions. These 

candidates will be considered to fill 

positions opened through completion of 

current member terms. Nominations are 

due by 5:00 p.m. ET on December 17, 

2024, using the IPRCC nomination 

webform: https://

www.surveymonkey.com/r/IPRCCnomination-form 

Dated: October 25, 2024. 

Walter J. Koroshetz, 

Director, National Institute of Neurological 

Disorders and Stroke, National Institutes of 

Health. 

[FR Doc. 2024–25241 Filed 10–30–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


lotter on DSK11XQN23PROD with NOTICES1